Atezolizumab
Atezolizumab anti-PD-L1) is a fully humanized IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1 but not the interaction of PD-L2 with PD-1.
Product Specifications
CAS Number
1380723-44-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
145 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Other Targets